Skip to main content
Article

Second-Generation AUTACs for Targeted Autophagic Degradation

Daiki TakahashiGraduate School of Life Sciences, Tohoku University, 2-1-1 Katahira, Aoba-ku, Sendai, Miyagi 980-8577, JapanTaiichi OraTakeda Pharmaceutical Company Limited, Fujisawa, Kanagawa 251-8555, JapanShigekazu SasakiTakeda Pharmaceutical Company Limited, Fujisawa, Kanagawa 251-8555, JapanNaoki IshiiTakeda Pharmaceutical Company Limited, Fujisawa, Kanagawa 251-8555, JapanToshio TanakaTakeda Pharmaceutical Company Limited, Fujisawa, Kanagawa 251-8555, JapanTakumi MatsudaGraduate School of Life Sciences, Tohoku University, 2-1-1 Katahira, Aoba-ku, Sendai, Miyagi 980-8577, JapanMutsuki IkedaGraduate School of Life Sciences, Tohoku University, 2-1-1 Katahira, Aoba-ku, Sendai, Miyagi 980-8577, JapanJun MoriyamaGraduate School of Life Sciences, Tohoku University, 2-1-1 Katahira, Aoba-ku, Sendai, Miyagi 980-8577, JapanNobuo ChoTakeda Pharmaceutical Company Limited, Fujisawa, Kanagawa 251-8555, JapanHiroshi NaraTakeda Pharmaceutical Company Limited, Fujisawa, Kanagawa 251-8555, JapanHironobu MaezakiTakeda Pharmaceutical Company Limited, Fujisawa, Kanagawa 251-8555, JapanMasahiro KamauraTakeda Pharmaceutical Company Limited, Fujisawa, Kanagawa 251-8555, JapanKenichiro ShimokawaTakeda Pharmaceutical Company Limited, Fujisawa, Kanagawa 251-8555, JapanHirokazu ArimotoGraduate School of Life Sciences, Tohoku University, 2-1-1 Katahira, Aoba-ku, Sendai, Miyagi 980-8577, Japan
2023en
ABI

Abstract

Targeted protein degradation via the ubiquitin-proteasome system has emerged as one of the most promising drug discovery modalities. Autophagy, another intracellular degradation system, can target a wide range of nonproteinous substrates as well as proteins, but its application to targeted degradation is still in its infancy. Our previous work revealed a relationship between guanine modification of cysteine residues on intracellular proteins and selective autophagy, resulting in the first autophagy-based degraders, autophagy-targeted chimeras (AUTACs). Based on the research background, all the reported AUTACs compounds contain cysteine as a substructure. Here, we examine the importance of this substructure by conducting SAR studies and report significant improvements in the degrader's activity by replacing cysteine with other moieties. Several derivatives showed sub-μM range degrading activity, demonstrating the increased practical value of AUTACs.

Identifiers

Citations and references

Cited by 20 references